Jimenez Freddy A.
- SEC CIK
- 0001838114
In the past year, 1 open-market sale filing worth $121.2K and no purchases.
Current role at each company
- CLDX Celldex Therapeutics, Inc.SVP & GENERAL COUNSELas of Jun 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $121.2K
- 1 filing
- Net
- −$121.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jimenez Freddy A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 (view filing) | Dec 4 | 4 days | Jimenez Freddy A.SVP & GENERAL COUNSEL | SSale | −4.17K | $29.10 | −$121.2K | −11.9%30.8K after | |
| Aug 15, 2025 (view filing) | Aug 13 | 2 days | Jimenez Freddy A.SVP & GENERAL COUNSEL | SSale | −771 | $24.77 | −$19.1K | −2.2%35.0K after | 2 lots |
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Jimenez Freddy A.SVP & GENERAL COUNSEL | SSale | −8.01K | $33.60 | −$269.0K | −23.6%25.9K after | |
| Aug 13, 2021 (view filing) | Aug 11 | 2 days | Jimenez Freddy A.SVP & General Counsel | PPurchase | +430 | $46.28 | +$19.9K | New position430 after |